01205nas a2200265 4500000000100000008004100001260001300042653001500055653001000070653001100080653001200091653001600103653001000119653002300129653002400152100001400176700002000190245007900210856005900289300000900348490000700357050003200364520052900396022001400925 1991 d c1991 Mar10aAdolescent10aAdult10aHumans10aleprosy10aMiddle Aged10aNepal10aPatient Compliance10aSelf Administration1 aTrier Y D1 aDe Soldenhoff R00aSelf-administered dapsone compliance of leprosy patients in eastern Nepal. uhttp://leprev.ilsl.br/pdfs/1991/v62n1/pdf/v62n1a08.pdf a53-70 v62 aInfolep Library - available3 a
Self-administered dapsone intake by leprosy patients in Eastern Nepal was monitored with a urine spot test. Of 341 outpatients 55 (16.1%) were found to be noncompliant. A significant relationship was found between noncompliance and age and between noncompliance and caste. Sex, disease classification, type of treatment, duration of treatment, history of leprosy reactions and travel time to the clinic did not influence the compliance. In remote areas the urine spot test can be useful in leprosy control programmes.
a0305-7518